MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Gilteritinib for the Treatment of ALK NSCLC
What the film says
This trial is for stage 4 ALK positive non small cell lung cancer that has progressed on other treatments, in adults.
The idea: reuse an approved drug. Gilteritinib is already FDA approved for a specific type of leukemia. The record says studies using ALK positive lung cancer cells showed activity against cells resistant to ALK drugs. Patients take it by mouth in 21 day cycles.
This phase 1 trial plans 30 patients and studies safety and the best dose. At the University of Michigan in Ann Arbor, Angel Qin leads it.
Public record; not medical advice.
Sources behind this film
Stage 4 ALK positive NSCLC progressed on other treatments, adults; Gilteritinib is already FDA approved for a specific type of leukemia; Studies with ALK positive lung cancer cells showed activity against resistant cells (stated as the registry's claim); By mouth, in 21 day cycles (+2 more lines)
The drug
Gilteritinib is a drug that is already FDA approved for the treatment of a specific type of leukemia. However, studies using ALK positive lung cancer cells demonstrate activity of gilteritinib against these resistant cells.
The study
This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with stage IV ALK positive non-small cell lung cancer (NSCLC) who have progressed on other treatments. While there are many approved targeted drugs for ALK NSCLC, resistance to these drugs frequently occur.
Therefore, in this clinical trial, the investigators plan to study the effect of gilteritinib in patients with ALK NSCLC.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.